Amphastar Pharmaceuticals AMPH Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's gain (loss) on disposition of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's gain (loss) on disposition of assets?
- Amphastar Pharmaceuticals (AMPH) reported gain (loss) on disposition of assets of -$4K in Q1 2026.
- How has Amphastar Pharmaceuticals's gain (loss) on disposition of assets changed year-over-year?
- Amphastar Pharmaceuticals's gain (loss) on disposition of assets decreased by 100.0% year-over-year, from -$2K to -$4K.
- What is the long-term trend for Amphastar Pharmaceuticals's gain (loss) on disposition of assets?
- Over 3 years (2021 to 2025), Amphastar Pharmaceuticals's gain (loss) on disposition of assets has grown at a -51.8% compound annual growth rate (CAGR), from -$348K to -$39K.